Stopping long-acting inhalers for chronic obstructive pulmonary disease (COPD) can lead to a sharp rise in flare-ups for about three months, a new study has revealed. This research by The University ...

Propeller Health, formerly Asthmapolis, has received FDA clearance for a platform that includes a new smart inhaler and is geared for patients with either asthma or COPD. "Our goal is to minimize or ...

Chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis, affects more than 30 million Americans and is the fourth leading cause of death worldwide. Many people ...

DIGITAL COPD inhaler training reduced technique errors and improved assessment of inspiratory capacity in a new study. COPD ...

Researchers conducted an observational study using real‑world data to compare the effectiveness and safety of initiating three fixed‑dose long‑acting muscarinic antagonist (LAMA)-long‑acting beta‑2 ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly ...

Inhalers that provide fast-acting treatment for people with certain respiratory conditions are contributing to greenhouse gas emissions, which can worsen both climate change and the conditions ...

Guiding people on how to correctly use inhaled medications via a phone-based program can help improve technique, according to a new study in the March 2026 issue of Chronic Obstructive Pulmonary ...

Humana Healthcare Research and University of Chicago Medicine study highlights promise of improving respiratory care through remote learning. A new study published in the Chronic Obstructive Pulmonary ...